Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma

Medicine and Dentistry

• Radiation Therapy 100%
• Protein P53 83%
• Programmed Cell Death 66%
• Cells 66%
• Radiation 66%
• In Vitro 50%
• Adenoviridae 50%
• Contusugene Ladenovec 50%
• Protein P53 50%
• Cell Viability 33%
• Neoplasm 33%
• Tumor Progression 33%
• Hepatocellular Carcinoma 33%
• Protein 16%
• Gene Therapy 16%
• Tumor Cell 16%
• Adenovirus Vector 16%
• P21 16%
• Gene Transfer 16%
• Caspase 3 16%
• Hepatocellular Carcinoma Cell Line 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Protein P53 83%
• Adenoviridae 50%
• Contusugene Ladenovec 50%
• Neoplasm 33%
• Tumor Growth 33%
• Liver Cell Carcinoma 33%
• Protein 16%
• Adenovirus Vector 16%
• Caspase 3 16%